Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review

References

• Bassetti M, Giacobbe DR, Giamarellou H, Viscoli C, Daikos G, Dimopoulos G, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect. 2018 Feb; 24:133–144.
   PubMed Web of Science ®Google Scholar
• Daikos G, Tsaousi S, Tzouvelekis L, Anyfantis I, Psichogiou M, Argyropoulou A, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58:2322–2328.
   PubMed Web of Science ®Google Scholar
• Munoz-Price L, Poirel L, Bonomo R, Schwaber M, Daikos G, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–796.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Trecarichi E, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70:2133–2143.
   PubMed Web of Science ®Google Scholar
• Surveillance of antimicrobial resistance in Europe. 2017. European Centre for Disease Prevention and Control. https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017. Published 2019. Accessed September 24, 2019.
   Google Scholar
• Salsano A, Giacobbe DR, Sportelli E, Olivieri G, Brega C, Di Biase C, et al. Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery. Interact Cardiovasc Thorac Surg.. 2016;23:762–768.
   PubMed Web of Science ®Google Scholar
• Jaworski R, Haponiuk I, Steffens M, Arlukowicz E, Irga-Jaworska N, Chojnicki M, et al. Colonization of multidrug resistant pathogens in a hybrid pediatric cardiac surgery center. aoms.. 2016;3:639–644.
   Google Scholar
• Abboud C, de Souza E, Zandonadi E, Borges L, Miglioli L, Monaco F, et al. Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control. J Hosp Infect. 2016;94:60–64.
   PubMed Web of Science ®Google Scholar
• Chan M, Yusuf E, Giulieri S, Perrottet N, Von Segesser L, Borens O, et al. A retrospective study of deep sternal wound infections: clinical and microbiological characteristics, treatment, and risk factors for complications. Diag Microbiol Infect Dis. 2016;84:261–265.
   PubMed Web of Science ®Google Scholar
• Freeman R. Predictors for infection following open-heart surgery. J Hosp Infect. 1991;18:299–307.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Corcione S, Salsano A, Del Puente F, Mornese Pinna S, De Rosa FG, et al. Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery. Exp Opin Pharmacother. 2019;20:751–772.
   PubMed Web of Science ®Google Scholar
• Kollef M, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser V. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666–675.
   PubMed Web of Science ®Google Scholar
• Yusuf E, Chan M, Renz N, Trampuz A. Current perspectives on diagnosis and management of sternal wound infections. IDR.. 2018; 11:961–968.
   Google Scholar
• van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8:460–469.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Del Bono V, Bruzzi P, Corcione S, Giannella M, Marchese A. Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study. Eur J Clin Microbiol Infect Dis.. 2016;36:663–669.
   PubMed Web of Science ®Google Scholar
• Giannella M, Trecarichi E, De Rosa FG, Del Bono V, Bassetti M, Lewis R, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20:1357–1362.
   PubMed Web of Science ®Google Scholar
• Kontopoulou K, Iosifidis E, Antoniadou E, Tasioudis P, Petinaki E, Malli E, et al. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection. J Med Microbiol. 2019;68:326–335.
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrobl Chemother. 2012;67:2976–2981.
   PubMed Web of Science ®Google Scholar
• Cronin KM, Poy Lorenzo YS, Olenski ME, Bloch AE, Visvanathan K, Waters MJ, et al. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case–control study. J Hosp Infect. 2017;96:111–115.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2014;58:3514–3520.
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Corcione S, Pagani N, Stella ML, Urbino R, Di Perri G, et al. High rate of respiratory MDR gram-negative bacteria in H1N1-ARDS treated with ECMO. Intensive Care Med. 2013;39:1880–1881.
   PubMed Web of Science ®Google Scholar
• Alicino C, Giacobbe DR, Orsi A, Tassinari F, Trucchi C, Sarteschi G, et al. Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis.. 2015;15.
   PubMed Web of Science ®Google Scholar
• Cristina ML, Alicino C, Sartini M, Faccio V, Spagnolo AM, Bono VD, et al. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area. J Infect Public Health. 2018;11:171–177.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Del Bono V, Mikulska M, Gustinetti G, Marchese A, Mina F, et al. Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy. Infection. 2017;45:849–856.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Salsano A, Del Puente F, Campanini F, Mariscalco G, et al. Reduced Incidence of carbapenem-resistant Klebsiella pneumoniae infections in cardiac surgery patients after implementation of an antimicrobial stewardship project. Antibiotics. 2019;8:132.
   Google Scholar
• Lombardi F, Gaia P, Valaperta R, Cornetta M, Tejada M, Di Girolamo L, et al. Emergence of carbapenem-resistant Klebsiella pneumoniae: progressive spread and four-year period of observation in a cardiac surgery division. BioMed Res Int. 2015;2015:1–7.
   Google Scholar
• Mehta Y, Purohit A, Trehan N, Daniel R, Pawar M. Resistance in gram-negative bacilli in a cardiac intensive care unit in India: risk factors and outcome. Ann Card Anaesth.. 2008;11:20.
   PubMedGoogle Scholar
• Heydarpour F, Rahmani Y, Heydarpour B, Asadmobini A. Nosocomial infections and antibiotic resistance pattern in open-heart surgery patients at Imam Ali Hospital in Kermanshah. Iran. GMS Hyg Infect Control. 2017;12:Doc07.
   PubMed Web of Science ®Google Scholar
• GöI M, Karahan M, Ulus A, Erdil N, Iscan Z, Karabiber N, et al. Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Cardiac Surgery.. 1998;13:252–259.
   PubMed Web of Science ®Google Scholar
• Jonkers D. Prevalence of 90-days postoperative wound infections after cardiac surgery. European J Cardio-Thorac Surg. 2003;23:97–102.
   PubMed Web of Science ®Google Scholar
• Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, Chatzipantazi V, et al. Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: Impact of infection control measures for restraining their dissemination. J Clin Microbiol. 2012;50:2618–2623.
   PubMed Web of Science ®Google Scholar
• Kohler P, Volling C, Green K, Uleryk E, Shah P, McGeer A. Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis. Infect Control Hosp Epidemiol.. 2017;38:1319–1328.
   PubMed Web of Science ®Google Scholar
• Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous MV. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016;71:1083–1087. Apr
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Tumbarello M, Del Bono V, Viscoli C; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva). Comment on: mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016;71:1743–1744.
   PubMed Web of Science ®Google Scholar
• Sabino S, Soares S, Ramos F, Moretti M, Zavascki A, Rigatto M. A cohort study of the impact of carbapenem-resistant Enterobacteriaceae Infections on mortality of patients presenting with sepsis. mSphere. 2019;4.
   PubMed Web of Science ®Google Scholar
• Tamma P, Huang Y, Opene B, Simner P. Determining the optimal carbapenem MIC that distinguishes carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother.. 2016;60:6425–6429.
   PubMed Web of Science ®Google Scholar
• Evagelopoulou P, Myrianthefs P, Markogiannakis A, Baltopoulos G, Tsakris A. Multidrug‐resistant Klebsiella pneumoniae mediastinitis safely and effectively treated with prolonged administration of tigecycline. Clin Infect Dis.. 2008;46:1932–1933.
   PubMed Web of Science ®Google Scholar
• Abboud C, Miglioli L, Romero A, Ibanes A, Della Togna D, Pereira R, et al. First report of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sternum osteomyelitis relapsing 6 years after mediastinitis following cardiac surgery. Int J Antimicrob Agents. 2017;49:262–263.
   PubMed Web of Science ®Google Scholar
• Abboud CS, Monteiro J, Stryjewski ME, Zandonadi EC, Barbosa V, Dantas D, et al. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics. Int J Antimicrob Agents. 2016;47:386–390.
   PubMed Web of Science ®Google Scholar
• Galvão LM, Oliveira A. P R D, Ibanês AS, Monteiro J, Inoue F, Dantas DC, et al. Fatal case of donor-derived colistin-resistant carbapenemase-producing Klebsiella pneumoniae transmission in cardiac transplantation. Brazilian J Infect Dis. 2018;22:235–238.
   PubMed Web of Science ®Google Scholar
• Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, Cipullo R, Moreira JCM, Baia C, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis. 2012;14:198–205.
   PubMed Web of Science ®Google Scholar
• Avery L, Nicolau D. Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. Exp Opin Invest Drugs. 2018;27:325–338.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR gram-negative bacteria. Front Med.. 2019;6.
   Web of Science ®Google Scholar
• Giacobbe DR, Mikulska M, Viscoli C. Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria. Exp Rev Clin Pharmacol. 2018;11:1219–1236.
   PubMed Web of Science ®Google Scholar
• Davido B, Fellous L, Lawrence C, et al. Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61: e01008–17.
   PubMed Web of Science ®Google Scholar
• FDA Drug Safety Communication. FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. [cited 2019 Jan 20]. Available from: https://www.fda.gov/drugs/drugsafety/ucm369580.htm.).
   Google Scholar
• Giacobbe DR, Del Bono V, Trecarichi E, De Rosa FG, Giannella M, Bassetti M, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study. Clin Microbiol Infect. 2015;21:1106.e1–1106.e8.
   Web of Science ®Google Scholar
• Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Exp Opin Pharmacother. 2014;15:1351–1370.
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Antoniadou A, Giamarellou H. Combination therapy for extensively-drug resistant gram-negative bacteria. Exp Rev Anti-infect Ther. 2017;15:1123–1140.
   PubMed Web of Science ®Google Scholar
• Tsuji B, Pogue J, Zavascki A, Paul M, Daikos G, Forrest A, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy.. 2019;39:10–39.
   PubMed Web of Science ®Google Scholar
• Cancelli F, Oliva A, De Angelis M, Mascellino M, Mastroianni C, Vullo V. Role of double-carbapenem regimen in the treatment of infections due to carbapenemase producing carbapenem-resistant Enterobacteriaceae: a single-center, observational study. BioMed Res Int. 2018;2018:1–8.
   Google Scholar
• Oliva A, Giacobbe DR, Di Luca M, Miller N. New insights into infections due to multidrug resistant gram negative bacteria: the interplay between lab and clinic. BioMed Res Int. 2018;2018:1–3.
   Google Scholar
• Montelione N, Menna D, Sirignano P, Capoccia L, Mansour W, Speziale F. Open conversion after aortic endograft infection caused by colistin-resistant, carbapenemase-producing Klebsiella pneumoniae. Texas Heart Inst J. 2016;43:453–457.
   PubMed Web of Science ®Google Scholar
• Cheng V, Abdul-Aziz M, Roberts J, Shekar K. Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. J Thorac Dis. 2018;10:S629–S641.
   PubMed Web of Science ®Google Scholar
• Pea F, Viale P, Pavan F, Furlanut M. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet. 2007;46:997–1038.
   PubMed Web of Science ®Google Scholar
• Kempke A, Leino A, Daneshvar F, Lee J, Mueller B. Antimicrobial doses in continuous renal replacement therapy: a comparison of dosing strategies. Crit Care Res Pract. 2016;2016:1–6.
   Google Scholar
• Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61–e111.
   PubMed Web of Science ®Google Scholar
• Rello J, Solé-Lleonart C, Rouby J-J, Chastre J, Blot S, Poulakou G, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2017;23:629–639.
   PubMed Web of Science ®Google Scholar